NCT02974374
- Conditions
- Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
- Locations
-
- Pfizer New Haven Clinical Research Unit New Haven, Connecticut, United States
Clinical trial condition
Fatty Liver
Explore clinical trials studying Fatty Liver. Study availability and eligibility vary by location and protocol.
953 public trials
145 recruiting studies
Fatty Liver trial results
NCT01966627
- Conditions
- Body Weight, Digestive System Diseases, Fatty Liver, +11 more
- Locations
-
- Yale University New Haven, Connecticut, United States
NCT00596934
- Conditions
- Body Weight, Digestive System Diseases, Fatty Liver, +14 more
- Locations
-
- University of Michigan Ann Arbor, Michigan, United States
Completed
Drug-drug Interaction Study Between EDP-305, Intraconazole and Rifampin in Healthy Volunteers
NCT03213145
- Conditions
- Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
- Locations
-
- Pharmaceutical Research Associates, Inc., Lenexa, Kansas, United States
NCT02329405
- Conditions
- Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
- Locations
-
- Oulu University Hospital Oulu, Finland
NCT01477307
- Conditions
- Body Weight, Digestive System Diseases, Fatty Liver, +10 more
- Locations
-
- Geneva University Hospital Geneva, Switzerland
NCT02303314
- Conditions
- Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
- Locations
-
- Shiraz University of Medical Sciences Shiraz, Fars, Iran
NCT03276039
- Conditions
- Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
- Locations
-
Not specified
Completed
Multiple Ascending Dose and DDI Study
NCT03031119
- Conditions
- Digestive System Diseases, Fatty Liver, Healthy Volunteers, +2 more
- Locations
-
- Pfizer Clinical Research Unit Brussels, Belgium
Completed
Serum Ferritin as a Non-invasive Marker in Prediction of Hepatic Fibrosis Among NAFLD Patients
NCT03250572
- Conditions
- Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
- Locations
-
Not specified